Analysis of calreticulin mutations in Chinese patients with essential thrombocythemia: Clinical implications in diagnosis, prognosis and treatment

Leukemia

Volumn 28, Issue 9, 2014, Pages 1912-1914

  Fu, R ^a   Xuan, M ^a   Zhou, Y ^a   Sun, T ^a   Bai, J ^a   Cao, Z ^a   Zhang, L ^a   Li, H ^a   Zhang, D ^a   Zhang, X ^a   Lv, C ^a   Xue, F ^a   Liu, X ^a   Yang, R ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALRETICULIN;

ADULT; AGED; BONE MARROW BIOPSY; CELL PROLIFERATION; CHINESE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; LETTER; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEGAKARYOCYTE; OVERALL SURVIVAL; POINT MUTATION; PRIORITY JOURNAL; PROGNOSIS; SOMATIC MUTATION; THROMBOCYTE COUNT; THROMBOCYTHEMIA; THROMBOSIS;

CALRETICULIN; HUMANS; MUTATION; PROGNOSIS; THROMBOCYTHEMIA, ESSENTIAL;

EID: 84908275324     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2014.138     Document Type: Letter

References (15)

1. Klampfl T, Gisslinger H, Harutyunyan AS, Nivarthi H, Rumi E, Milosevic JD., et al. Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med. 2013; 369: 2379-2390
2. Nangalia J, Massie CE, Baxter EJ, Nice FL, Gundem G, Wedge DC., et al. Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2. N Engl J Med. 2013; 369: 2391-2405
3. Rumi E, Pietra D, Ferretti V, Klampfl T, Harutyunyan AS, Milosevic JD., et al. JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes. Blood. 2013; 123: 1544-1551
4. Rotunno G, Mannarelli C, Guglielmelli P, Pacilli A, Pancrazzi A, Pieri L., et al. Impact of Calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia. Blood. 2013; 123: 1552-1555
5. Lundberg P, Karow A, Nienhold R, Looser R, Hao-Shen H, Nissen I., et al. Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms. Blood. 2014; 123: 2220-2228
6. Tefferi A, Pardanani A. Genetics: CALR mutations and a new diagnostic algorithm for MPN. Nat Rev Clin Oncol. 2014; 11: 125-126
7. Tefferi A, Guglielmelli P, Lasho TL, Rotunno G, Finke C, Mannarelli C., et al. CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients. Leukemia. 2014; 28: 1494-1500
8. Guglielmelli P, Nangalia J, Green AR, Vannucchi AM. CALR mutations in myeloproliferative neoplasms: Hidden behind the reticulum. Am J Hematol. 2014; 89: 453-456
9. Tefferi A, Lasho TL, Finke CM, Knudson RA, Ketterling R, Hanson CH., et al. CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons. Leukemia. 2014; 28: 1472-1477
10. Tefferi A, Lasho TL, Finke C, Belachew AA, Wassie EA, Ketterling RP., et al. Type 1 vs type 2 calreticulin mutations in primary myelofibrosis: differences in phenotype and prognostic impact. Leukemia. 2014; 28: 1568-1570
11. Tefferi A, Vardiman JW. Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia. 2008; 22: 14-22
12. Green MR, Gentles AJ, Nair RV, Irish JM, Kihira S, Liu CL., et al. Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma. Blood. 2013; 121: 1604-1611
13. Lasho TL, Elliott MA, Pardanani A, Tefferi A. CALR mutation studies in chronic neutrophilic leukemia. Am J Hematol. 2014; 89: 450
14. Vannucchi AM, Rotunno G, Bartalucci N, Raugei G, Carrai V, Balliu M., et al. Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value. Leukemia. 2014; 28: 1811-1818
15. Barbui T, Finazzi G, Carobbio A, Thiele J, Passamonti F, Rumi E., et al. Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-Thrombosis). Blood. 2012; 120: 5128-5133